Invitro International (IVRO)
InVitro International, Inc. is a healthcare equipment and supplies company focused on non-animal testing solutions in the United States and international markets. The company develops test kits used to assess ocular and dermal irritancy and skin corrosivity, including the Irritection Assay System and Corrositex. Its offerings also include customized technology support for system installation and testing processes, along with independent laboratory and consulting services related to irritancy and corrosivity testing. These products and services are used across cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, hazardous waste, and transportation industries. Incorporated in 1985, InVitro International is headquartered in Placentia, California, and its common stock trades on OTC Markets under the symbol IVRO.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-IVRO
|
—
|
—
|
—
|
—
|
—
|
—
|
Good
|
—
|
—
|
—
|
0.0%
|
September 23, 2026
|
—
|
—
|
—
|
1.832 M
|
—
|
—
|
—
|
—
|
—
|
—
|